Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena ...
FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.
Over the past decades, some medical researchers and neuroscientists have been exploring the possible therapeutic effects of ...
Republican Sen. Lindsey Graham is running for another term but faces well-funded challengers in both the Republican primary and potentially in the general election. Candidates must get majority ...
Zacks Investment Research on MSN
Biogen wins FDA approval for subcutaneous starter dose of Leqembi
Shares of Biogen BIIB rose nearly 5% yesterday after the company announced that the FDA approved a subcutaneous (SC) ...
Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive biology and ...
FDA approves subcutaneous isatuximab-irfc for multiple myeloma indications, offering an efficient delivery alternative to intravenous administration. The US Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results